top of page

Quebec Pancreas Cancer Study

Clinicaltrials.gov ID

NCT04104230

Status

Recruiting

Study Type

Observational

Sponsor

George Zogopoulos

Start Date

11 mars 2012

Anticipated End Date

1 janvier 2025

Study Contact
!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

About the Study

The Quebec Pancreas Cancer Study is a prospective clinic-based study consisting of clinical, family history and epidemiologic data, with accompanying biospecimens, from patients diagnosed with either pancreas cancer, a related cancer or a related pre-cancerous condition, and their families.

Conditions

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

Inclusion/Exclusion Criteria?

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

Primary, Secondary, Other Outcome Measures??

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

Locations in Canada

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

About the Study

The Quebec Pancreas Cancer Study is a prospective clinic-based study consisting of clinical, family history and epidemiologic data, with accompanying biospecimens, from patients diagnosed with either pancreas cancer, a related cancer or a related pre-cancerous condition, and their families.

Conditions

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

Interventions

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.
!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

Locations in Canada

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.
  • Instagram
  • Facebook
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

Le Collectif Canadien pour le cholangiocarcinome (C3) est financé par une subvention d'équipe révolutionnaire de la Société Canadienne du cancer en partenariat avec les Instituts de recherche en santé du Canada. Les fonds de la subvention pour le C3 sont gérés par l'Institut de recherche de l'Hôpital d'Ottawa, qui sert d'institut principal pour toutes les opérations collaboratives.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page